Half Year Results

The strong uptake of the newly launched products  show the value of scientific innovation for patients, bringing real progress in areas with significant unmet medical need.

Boehringer Ingelheim reports first-half 2026 sales growth

European Commission approves JASCAYD®,  well-tolerated, novel oral treatment for IPF and PPF

News & Stories

How open innovation gives scientific discoveries a second life

Through opn2SCREEN researchers identified a new potential therapeutic approach for gastrointestinal neuroendocrine tumors.

Planning certainty is the foundation for innovation

Reliable framework conditions secure investment, progress and supply in Germany.

Cities teaming up to enhance stroke care

Discover how Angels Cities build collaborations to act quickly on stroke symptoms.

Social impact investing in Africa

With our support, Farm Alert, a social enterprise founded by a Nigerian veterinarian, is making social impact and transforming animal care in West Africa.

Understanding biomarker testing in lung cancer

Knowing biomarker status is essential for informed healthcare decisions.

Helping Ecuador fight rabies

Discover how we're planting the seeds of change in the next generation through our Stop Rabies program.

When it does - it's powerful. Learn from our colleagues what makes their work meaningful.